EQT Fund Management S.a r.l.

Position in AGMB — Agomab Therapeutics NV

CIK 1834239 LUXEMBOURG, N4

Position in AGMB

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$53,939,496

New position

Shares Held

5,141,992

first reported quarter

Ownership

10.4%

of shares outstanding

% of Portfolio

5.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EQT Fund Management S.a r.l. holds $420,905,779 across 4 Biotechnology names. AGMB ranks #4 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OCS	Oculis Holding AG	5,900,294	$156,888,817
2	EVMN	Evommune, Inc.	4,929,633	$113,332,262
3	PHVS	Pharvaris N.V.	3,424,609	$96,745,204
4	AGMB	Agomab Therapeutics NV This page	5,141,992	$53,939,496

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,939,496	5,141,992	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.